G.L. Scherphof
Impact in
- Biochemistry top 5%
- Lipid metabolism and biosynthesis
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Lipid Membrane Structure and Behavior 7
- Metabolomics and Mass Spectrometry Studies 3
- Oncology 6
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Toos Daemen (5 shared papers)Elisabeth G.E. de Vries (1 shared paper)L.L.M. Van Deenen (2 shared papers)L.M.G. Van Golde (1 shared paper)T.M.A.R. Dubbelman (1 shared paper)Fred Possmayer (1 shared paper)J.W. Dijkstra (2 shared papers)C.E. Hulstaert (1 shared paper)
- Journals
- Biochimica et Biophysica Acta (BBA) - Biomembranes (2 papers)Biochemical Journal (2 papers)Journal of Hepatology (1 paper)Critical Reviews in Oncology/Hematology (1 paper)Hepatology (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
G.L. Scherphof
21 papers receiving 877 citations
Peers
Comparison fields: 5 of 86
- Biochemistry 144
- Immunology 198
- Biomaterials 111
- Molecular Biology 447
- Clinical Biochemistry 42
Countries citing papers authored by G.L. Scherphof
This map shows the geographic impact of G.L. Scherphof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.L. Scherphof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.L. Scherphof more than expected).
Fields of papers citing papers by G.L. Scherphof
This network shows the impact of papers produced by G.L. Scherphof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.L. Scherphof. The network helps show where G.L. Scherphof may publish in the future.
Co-authors
The 25 scholars most cited alongside G.L. Scherphof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 299 | |
| 2 | 1969 | 157 | |
| 3 | 1984 | 88 | |
| 4 | A non-exchangeable fluorescent phospholipid analog as a membrane traffic marker of the endocytic pathway. | 1990 | 61 |
| 5 | 1997 | 54 | |
| 6 | 1966 | 38 | |
| 7 | 1994 | 36 | |
| 8 | 1999 | 28 | |
| 9 | 1995 | 22 | |
| 10 | 1991 | 20 | |
| 11 | 1979 | 19 | |
| 12 | 1988 | 17 | |
| 13 | 1990 | 15 | |
| 14 | 1989 | 14 | |
| 15 | 1992 | 12 | |
| 16 | 1992 | 12 | |
| 17 | 1995 | 9 | |
| 18 | 1982 | 7 | |
| 19 | 1976 | 5 | |
| 20 | 1982 | 3 |
About G.L. Scherphof
G.L. Scherphof is a scholar working on Molecular Biology, Oncology, Nutrition and Dietetics, Epidemiology and Biomaterials, having authored 21 papers that have together received 918 indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (7 papers), Fatty Acid Research and Health (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Lipid metabolism and biosynthesis (2 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Biochemistry (144 citations), Immunology (198 citations), Biomaterials (111 citations), Molecular Biology (447 citations) and Clinical Biochemistry (42 citations). G.L. Scherphof has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Toos Daemen, Elisabeth G.E. de Vries, L.L.M. Van Deenen, L.M.G. Van Golde, T.M.A.R. Dubbelman, Fred Possmayer, J.W. Dijkstra, C.E. Hulstaert, Dick Hoekstra and Martin ter Beest. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Biochemical Journal, Journal of Hepatology, Critical Reviews in Oncology/Hematology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.